After adjustment for sex, age, and race, IL-18 levels were also significantly associated with risk of hospitalization day burden [P-value = 0.03, beta (β) = 5.68 days per natural log unit 1 increase in log (IL-18) levels] defined as total number of days hospitalized after COVID-19 diagnosis (Fig. 1b). Here, IL18 is linked to COVID-19.